As of 2026-01-28, the Relative Valuation of Antares Pharma Inc (ATRS) is 6.47 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 15.7%.
The range of the Relative Valuation is 6.23 - 6.79 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 18.7x - 20.4x | 19.4x |
| Fair Price | 6.23 - 6.79 | 6.47 |
| Upside | 11.5% - 21.5% | 15.7% |
| Date | P/E |